ALGS vs SYK · rev $2.8M vs P/E 35, rev $6.59B
Aligos Therapeutics Inc (ALGS) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported ALGS revenue for 2026-06-30 was $2.8M. Net income was -$24.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALGS currently screens at market cap $44.1M.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
ALGS currently screens at market cap $44.1M. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the ALGS and SYK stock pages for the full models.
Not investment advice.